Active fragments of angiotensin II: Enzymatic pathways of synthesis and biological effects

被引:80
作者
Ardaillou, R
机构
[1] Hôpital Tenon, 75020 Paris
关键词
D O I
10.1097/00041552-199701000-00006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin (Ang) II is not the only active peptide of the renin-angiotensin system. Several of its degradation products including Ang Ill (obtained by deletion of the N terminal amino acid), Ang IV (obtained by deletion of the two N terminal amino acids) and Ang II(1-7) (obtained by deletion of the C terminal amino acid) also possess biological functions, These peptides are formed via the activity of several enzymes, aminopeptidase A for Ang Ill, aminopeptidases la and N for Ang IV, prolylendopeptidase and carboxypeptidases for Ang II(1-7). Ang Ill possesses most of the properties of Ang II and shares the same receptors. This peptide is particularly important in brain and pituitary physiology and plays a major role in the secretion of arginine vasopressin. Ang IV possesses its own receptors distinct from AT(1) and AT(2). Some of its effects (for example, stimulation of the synthesis of the type 1 inhibitor of plasminogen activator by endothelial cells) were previously attributed to Ang II. Others are opposed to Ang II effects (renal and cerebral vasodilation), Its role in vascular, renal and cerebral physiology remains to be determined. Ang II(1-7) exhibits direct and indirect effects, the latter resulting from Ang II(1-7)-dependent formation of nitric oxide and vasodilatory prostaglandins. Ang II(1-7) recognizes both specific receptors and AT(1) receptors as shown by the partial antagonistic properties of losartan, Ang II(1-7) plays essentially a role in the control of the hydroelectrolytic balance by increasing glomerular filtration rate, urinary output and sodium excretion rate.
引用
收藏
页码:28 / 34
页数:7
相关论文
共 73 条
[1]  
ABDUHL P, 1994, BRAIN RES B, V35, P289
[2]  
AHMAD S, 1990, J PHARMACOL EXP THER, V252, P643
[3]   PRESSOR AND REFLEX SENSITIVITY IS ALTERED IN SPONTANEOUSLY HYPERTENSIVE RATS TREATED WITH ANGIOTENSIN-(1-7) [J].
BENTER, IF ;
DIZ, DI ;
FERRARIO, CM .
HYPERTENSION, 1995, 26 (06) :1138-1144
[4]   ANTIHYPERTENSIVE ACTIONS OF ANGIOTENSIN-(1-7) IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
BENTER, IF ;
FERRARIO, CM ;
MORRIS, M ;
DIZ, DI .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (01) :H313-H319
[5]   CHARACTERIZATION OF A BINDING-SITE FOR ANGIOTENSIN-IV ON BOVINE AORTIC ENDOTHELIAL-CELLS [J].
BERNIER, SG ;
SERVANT, G ;
BOUDREAU, M ;
FOURNIER, A ;
GUILLEMETTE, G .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 291 (02) :191-200
[6]   PROXIMAL TUBULAR SECRETION OF ANGIOTENSIN-II IN RATS [J].
BRAAM, B ;
MITCHELL, KD ;
FOX, J ;
NAVAR, LG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05) :F891-F898
[7]   ANGIOTENSIN-II AND ITS 3-7 FRAGMENT IMPROVE RECOGNITION BUT NOT SPATIAL MEMORY IN RATS [J].
BRASZKO, JJ ;
KULAKOWSKA, A ;
WISNIEWSKI, K .
BRAIN RESEARCH BULLETIN, 1995, 37 (06) :627-631
[8]  
CHANSEL D, 1995, J AM SOC NEPHROL, V6, P734
[9]   DIFFERENTIAL INHIBITION OF AMINOPEPTIDASE-A AND AMINOPEPTIDASE-N BY NEW BETA-AMINO THIOLS [J].
CHAUVEL, EN ;
LLORENSCORTES, C ;
CORIC, P ;
WILK, S ;
ROQUES, BP ;
FOURNIEZALUSKI, MC .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (18) :2950-2957
[10]   ANALYSIS OF RESPONSES TO ANGIOTENSIN-IV IN THE PULMONARY VASCULAR BED OF THE CAT [J].
CHENG, DY ;
DEWITT, BJ ;
DENT, EL ;
NOSSAMAN, BD ;
KADOWITZ, PJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 261 (1-2) :223-227